Diyetsel Etmenler, Tip 2 Diyabet ve İnflamasyon

Year 2018, Volume: 8 Issue: 4, 686 - 694, 30.12.2018

Tuba Yalçın Neslişah Rakıcıoğlu

https://doi.org/10.31832/smj.455293

Cited By: 1

Abstract

Adipoz doku;
İnterlökin-6, Tümör Nekröz Faktör-α, C-Reaktif Protein gibi inflamatuvar
belirteçler ve adiponektin gibi adipokinleri salgılayan en önemli endokrin
organlardan biridir. Tüm bu inflamatuvar faktörler inflamasyon, inflamatuvar
yanıt ve Tip 2 diyabet ile ilişkilidir.  Modern toplumlarda majör dejeneratif
hastalıkların oluşumunda kronik inflamasyonun artan rolü, araştırmacıları
beslenme ve diyet örüntüsünün inflamatuvar belirteçler üzerindeki etkisini
araştırmaya yönlendirmiştir. Bu derleme yazıda diyetsel etmenlerin Tip
2 diyabet ve inflamasyon üzerindeki etkisi tartışılmıştır.

Keywords

Diyabet, Adiponektin, inflamatuvar belirteçler, Diyetsel faktörler, Glisemik yük

References

• 1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diab Res Clin Pract 2013; 103:137-49.2. Sheng T, Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. Journal of Genetics and Genomics 2008; 35(6):321-6.3. Garg A. Regional Adiposity and Insulin Resistance. The Journal of Clinical Endocrinology & Metabolism 2004; 89(9):4206-10.4. Das U. Is obesity an inflammatory condition? Nutrition 2001; 17(11):953-66.5.Keane KN, Cruzat VF, Carlessi R, de Bittencourt PIH, Newsholme P. Molecular events linking oxidative stress and inflammation to insulin resistance and β-cell dysfunction. Oxidative Medicine and Cellular Longevity 2015; (1):15.6. Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutrition, Metabolism and Cardiovascular Diseases 2004; 14(5):228-32.7. King GL. The role of inflammatory cytokines in diabetes and its complications. Journal of Periodontology 2008; 79(8):1527-34.8. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokine & Growth Factor Reviews 2003; 14(5):447-55.9.Silva D, Pais de Lacerda A. High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease. Revista Portuguesa de Cardiologia (English Edition) 2012; 31(11):733-45.10. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004; 145(1):367-83.11. Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Critical Care 2011;15(2):221.12. Attar MJH, Mohammadi S, Karimi M, Hosseinnezhad A, Hosseini SH, Eshraghian MR, et al. Association of adiponectin with dietary factors and cardiovascular risk factors in type 2 diabetes mellitus patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2013;7(1):3-7.13. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. The J Clin Invest 1994; 94(4):1543.14. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27(3):813-23.15. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose Expression of Tumor Necrosis Factor- alpha: Direct Role in Obesity-Linked Insulin Resistance. Science 1993; 259(5091):87-91.16. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. The J Clin Invest 1995; 95(5):2111.17. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. Int J Clin Endocrinol Metab 1998; 83(8):2907-10.18. Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes. Am Diabetes Assoc 2013.19. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine & Growth Factor Reviews 2002; 13(4):357-68.20. Zunino SJ, Storms DH, Stephensen CB. Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. The Journal of Nutrition 2007; 137(5):1216-21.21. Lukic L, Lalic NM, Rajkovic N, Jotic A, Lalic K, Milicic T, et al. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive intervention. International Journal of Environmental Research and Public Health 2014; 11(4):3586-98.22. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and Insulin Resistance. Int J Clin Endocrinol Metab 2004; 89(2):447-52.23. van Zanten JV. C - reactive protein (CRP). In: Gellman MD, Turner JR, editors. Encyclopedia of Behavioral Medicine. New York, NY: Springer New York; 2013. p. 519-20.24. Prasad K. C‐Reactive Protein (CRP)‐Lowering Agents. Cardiovascular Therapeutics 2006; 24(1):33-50.25. Bozzetto L, De Natale C, Di Capua L, Della Corte G, Patti L, Maione S, et al. The association of hs-CRP with fasting and postprandial plasma lipids in patients with type 2 diabetes is disrupted by dietary monounsaturated fatty acids. Acta Diabetologica 2013; 50(2):273-6.26. Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine 2016; 86:100-9.27. Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obesity Reviews 2013; 14(3):232-44.28. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007; 56(3):872-8.29. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. Int J Clin Endocrinol Metab 2005; 90(8):4542-8.30. Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, et al. Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. Journal of Internal Medicine 2013; 274(2):163-75.31. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol 2004; 61(3):332-8.32. De Luis D, Aller R, Izaola O, Gonzalez Sagrado M, Bellioo D, Conde R. Effects of a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults. Hormone Research in Paediatrics 2007; 67(6):296-300.33. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. The Lancet 2002; 360(9326):57-8.34. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. The Lancet 2003; 361(9353):226-8.35. Choi K, Lee J, Lee K, Seo J, Oh J, Kim S, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004; 61(1):75-80.36. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302(2):179-88.37. Yamauchi T, Kamon J, Minokoshi Ya, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002; 8(11):1288-95.38. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 2001; 7(8):947-53.39. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology & Metabolism 2002; 13(2):84-9.40. Turer A, Scherer P. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012; 55(9):2319-26.41. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003; 52(2):239-43.42. Nilsson PM, Engström G, Hedblad B, Frystyk J, Persson MM, Berglund G, et al. Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26(12):2758-62.43. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 2000; 102(11):1296-301.44. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96(5):1723-32.45. Dietze-Schroeder D, Sell H, Uhlig M, Koenen M, Eckel J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005;54(7):2003-11.46. Kishida K, Funahashi T, Shimomura I. Adiponectin as a routine clinical biomarker. Best Practice & Research Clinical Endocrinology & Metabolism 2014; 28(1):119-30.47. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. Journal of Allergy and Clinical Immunology 2008; 121(2):326-30.48. Galland L. Diet and inflammation. Nutr Clin Pract 2010; 25:634–40.49. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. BJN 2011; 106(S3):S1-S78.50. Chuang S-C, Vermeulen R, Sharabiani MT, Sacerdote C, Saberi Hosnijeh F, Berrino F, et al. The intake of grain fibers modulates cytokine levels in blood. Biomarkers 2011;16(6):504-10.51. Jaacks LM, Crandell J, Liese AD, Lamichhane AP, Bell RA, Dabelea D, et al. No association of dietary fiber intake with inflammation or arterial stiffness in youth with type 1 diabetes. Journal of Diabetes and Its Complications. 2014;28(3):305-10.52. Jenkins D, Wolever T, Taylor RH, Barker H, Fielden H, Baldwin JM, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. The AJCN 1981;34(3):362-6.53. Liu S, Chou EL. Dietary glycemic load and type 2 diabetes: modeling the glucose-raising potential of carbohydrates for prevention. The AJCN 2010; 92(4):675-7.54. Sluijs I, van der Schouw YT, Spijkerman AM, Hu FB, Grobbee DE, Beulens JW. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition–Netherlands (EPIC-NL) study. The AJCN 2010; 92(4):905-11.55. Griffith JA, Ma Y, Chasan-Taber L, Olendzki BC, Chiriboga DE, Stanek EJ, et al. Association between dietary glycemic index, glycemic load, and high-sensitivity C-reactive protein. Nutrition 2008; 24(5):401-6.56. Kelly KR, Haus JM, Solomon TP, Patrick-Melin AJ, Cook M, Rocco M, et al. A low-glycemic index diet and exercise intervention reduces TNFα in isolated mononuclear cells of older, obese adults. The Journal of Nutrition 2011; 141(6):1089-94.57. Vrolix R, Mensink RP. Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome. The AJCN 2010; 92(2):366-74.58. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutrition Reviews 2001; 59(5):129-39.59. Slavin JL. Dietary fiber and body weight. Nutrition 2005; 21(3):411-8.60. Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A, et al. Health benefits of dietary fiber. Nutrition Reviews 2009; 67(4):188-205.61. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ, et al. Association between dietary fiber and serum C-reactive protein. The AJCN 2006; 83(4):760-6.62. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. The American Journal of Cardiology 2003; 92(11):1335-9.63. Ajani UA, Ford ES, Mokdad AH. Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. The Journal of Nutrition 2004; 134(5):1181-5.64. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. BJN 2007; 98(4):807-13.65. Sluijs I, Beulens JW, Spijkerman AM, Grobbee DE, Van der Schouw YT. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care 2010; 33(1):43-8.66. Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Am Coll Nutr 2012; 31(4):243-58.67. Hermsdorff HHM, Zulet MÁ, Abete I, Martínez JA. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. EJCN 2011; 50(1):61-9.68. Santesso N, Akl E, Bianchi M, Mente A, Mustafa R, Heels-Ansdell D, et al. Effects of higher-versus lower-protein diets on health outcomes: a systematic review and meta-analysis. EJCN 2012; 66(7):780-8.69. Gögebakan Ö, Kohl A, Osterhoff MA, van Baak MA, Jebb SA, Papadaki A, et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors. Circulation 2011;124(25):2829-38.70. Van Woudenbergh GJ, Kuijsten A, Tigcheler B, Sijbrands EJ, Van Rooij FJ, Hofman A, et al. Meat Consumption and Its Association with C - reactive protein and Incident Type 2 Diabetes. Diabetes Care 2012; 35(7):1499-505.71. Ratliff JC, Mutungi G, Puglisi MJ, Volek JS, Fernandez ML. Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men. Nutrition & Metabolism 2008; 5(1):6.72. He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R, et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). The American Journal of Cardiology 2009; 103(9):1238-43.73. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108(2):155-60.74. Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, et al. Effects of n− 6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. The AJCN 2012; 95(5):1003-12.75. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013; 346:8707.76. Nielsen MS, Schmidt EB, Stegger J, Gorst-Rasmussen A, Tjonneland A, Overvad K. Adipose tissue arachidonic acid content is associated with the risk of myocardial infarction: a Danish case-cohort study. Atherosclerosis 2013; 227(2):386-90.77. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2006; 26(5):995-1001.78. Panagiotakos DB, Dimakopoulou K, Katsouyanni K, Bellander T, Grau M, Koenig W, et al. Mediterranean diet and inflammatory response in myocardial infarction survivors. Int J Epidemiol 2009; 38(3):856-66.79. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, et al. Dietary intake of trans fatty acids and systemic inflammation in women. The American Journal of Clinical Nutrition 2004; 79(4):606-12.80. Tannock LR, O’Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, et al. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 2005; 111(23):3058-62.81. García OP, Ronquillo D, del Carmen Caamaño M, Camacho M, Long KZ, Rosado JL. Zinc, vitamin A, and vitamin C status are associated with leptin concentrations and obesity in Mexican women: results from a cross-sectional study. Nutrition & Metabolism 2012; 9(1):59.82. Zavala G, Long KZ, García OP, del Carmen Caamaño M, Aguilar T, Salgado LM, et al. Specific micronutrient concentrations are associated with inflammatory cytokines in a rural population of Mexican women with a high prevalence of obesity. BJN 2013; 109(4):686-94.83. Ford E, Liu S, Mannino D, Giles W, Smith S. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. EJCN 2003;57(9):1157-63.84. Walston J, Xue Q, Semba R, Ferrucci L, Cappola A, Ricks M, et al. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2005; 163(1):18-26.85. Suzuki K, Inoue T, Hashimoto S, Ochiai J, Kusuhara Y, Ito Y, et al. Association of serum carotenoids with high molecular weight adiponectin and inflammation markers among Japanese subjects. Clinica Chimica Acta 2010; 411(17):1330-4.86. Hozawa A, Jacobs Jr DR, Steffes MW, Gross MD, Steffen LM, Lee D-H. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006; 163(10):929-37.87. Woodward M, Rumley A, Lowe G, Tunstall‐Pedoe H. C‐reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology 2003; 122(1):135-41.88. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57(1):63-9.89. Bellia A, Garcovich C, D’Adamo M, Lombardo M, Tesauro M, Donadel G, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Internal and Emergency Medicine 2013; 8(1):33-40.90. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29(3):650-6.91. Van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 2006; 29(10):2238-43.92. Chen M-D, Lin P-Y, Tsou C-T, Wang J-J, Lin W-H. Selected metals status in patients with noninsulin-dependent diabetes mellitus. Biological Trace Element Research 1995; 50(2):119-24.93. Bond J, Failla ML, Unger D. Elevated manganese concentration and arginase activity in livers of streptozotocin-induced diabetic rats. Journal of Biological Chemistry 1983; 258(13):8004-9.